Biohaven to Discuss First Quarter 2022 Financial Results and Recent Business Developments on May 11, 2022

/PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative,...

Related Keywords

Jennifer Porcelli ,Biohaven Neuroinnovation ,Biohaven Pharmaceutical Holding Company Ltd ,Biohaven Pharmaceutical Holding Company ,Biohaven Pharmaceutical Ireland ,Pharmaceutical Holding Company ,